One Hurdle After Another: Safely Aligned With EU MDR, Turkish Medtechs Brace For New Efforts On Domestic Front
Executive Summary
Alignment with the MDR gave Turkish medtech access to the EU market, but in domestic pricing, costs, reimbursement and payment of hospital debts, industry might feel it is barely at the starting line.
You may also be interested in...
Good News For Medtech Regulation In The EU As Turkxit Is Avoided
Turkey and the EU have avoided the equivalent of a Brexit, or Swixit. Medtech trade will continue unhindered now it has been established that the EU/Turkey Customs Union will remain.
Health Care Policy Failings Are Eroding Medtechs’ Confidence In The Turkish Market
Late payment of hospital debts continues to haunt the Turkish medtech industry, which recently led a public demonstration in Ankara to focus the government’s attention on the issue. Medtech multinationals fear that the ongoing problems will mean Turkey losing the positive momentum it achieved during the pandemic.
Turkish Medtechs Face The Constant Challenge Of Sailing In Stormy Seas
The pandemic has exacerbated the problems of the Turkish medical device industry, which was already struggling for survival and growth in a hostile policy environment. Local blood bag manufacturer Kansuk Laboratory talked to Medtech Insight about the difficulties it faces.